Characterization of the dopamine transporter gene expression and binding sites in cultured human amniotic epithelial cells

Neuroscience Letters

Volumn 342, Issue 1-2, 2003, Pages 61-64

  Elwan, Mohamed A ^a,d   Ishii, Takashi ^a,b   Sakuragawa, Norio ^a,c  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c TOHO UNIVERSITY   (Japan)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amniotic epithelial cells; Dopamine Transporter; Reverse transcription polymerase chain reaction; 3H mazindol binding

Indexed keywords

DOPAMINE TRANSPORTER; IMIPRAMINE; MAZINDOL; NORTRIPTYLINE; PIPERAZINE DERIVATIVE; RADIOLIGAND;

AMNION CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; DATA ANALYSIS; DISSOCIATION; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG COMPETITION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

EID: 0037448107     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00235-0     Document Type: Article

References (24)

1. Alexander G.M., Schwartzman R.J., Brainard L., Gordon S.W., Grothusen J.R. Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys. Brain Res. 588:1992;261-269.
2. Ali S.F., Itzhak Y. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice. Ann. N. Y. Acad. Sci. 844:1998;122-130.
3. 3H]mazindol. J. Pharmacol. Exp. Ther. 253:1990;1206-1214.
4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
5. Donovan D.M., Vandenbergh D.J., Perry M.P., Bird G.S., Ingersoll R., Nanthakumar E., Uhl G.R. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures. Brain Res. Mol. Brain Res. 30:1995;327-335.
6. 3H]nomifensine to striatal membranes. Biochem. Pharmacol. 34:1985;1137-1144.
7. Elwan M.A. Synthesis of dopamine from L-3,4-dihydroxyphenylalanine by human amniotic epithelial cells. Eur. J. Pharmacol. 354:1998;R1-R2.
8. 3H]mazindol binding sites in cultured monkey amniotic epithelial cells. Neurosci. Lett. 279:2000;37-40.
9. Elwan M.A., Sakuragawa N. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. NeuroReport. 8:1997;3435-3438.
10. Eshleman A.J., Neve R.L., Janowsky A., Neve K.A. Characterization of a recombinant human dopamine transporter in multiple cell lines. J. Pharmacol. Exp. Ther. 274:1995;276-283.
11. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
12. Haberland N., Hetey L. Studies in postmortem dopamine uptake. I. Kinetic characterization of the synaptosomal dopamine uptake in rat and human brain after postmortem storage and cryopreservation. Comparison with noradrenaline and serotonin uptake. J. Neural. Transm. 68:1987;289-301.
13. 3H]mazindol binding sites in rat striatum by dopaminergic agents. Eur. J. Pharmacol. 250:1993;261-266.
14. Ishii T., Ohsugi K., Nakamura S., Sato K., Hashimoto M., Mikoshiba K., Sakuragawa N. Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system. Neurosci. Lett. 268:1999;131-134.
15. 3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol. 26:1984;35-44.
16. Kakishita K., Elwan M.A., Nakao N., Itakura T., Sakuragawa N. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp. Neurol. 165:2000;27-34.
17. Pavey G.M., Copolov D.L., Dean B. High-resolution phosphor imaging: validation for use with human brain tissue sections to determine the affinity and density of radioligand binding. J. Neurosci. Methods. 116:2002;157-163.
18. Pifl C., Hornykiewicz O., Giros B., Caron M.G. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. J. Pharmacol. Exp. Ther. 277:1996;1437-1443.
19. 3H]GBR 12,935 binding. Mol. Pharmacol. 45:1994;125-135.
20. Sakuragawa N., Enosawa S., Ishii T., Thangavel R., Tashiro T., Okuyama T., Suzuki S. Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver. J. Hum. Genet. 45:2000;171-176.
21. Sakuragawa N., Tohyama J., Yamamoto H. Immunostaining of human amniotic epithelial cells: possible use as a transgene carrier in gene therapy for inborn errors of metabolism. Cell Transplant. 4:1995;343-346.
22. Wiener H.L., Hashim A., Lajtha A., Sershen H. Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier. Eur. J. Pharmacol. 163:1989;191-194.
23. Wu X., Gu H.H. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene. 233:1999;163-170.
24. Zimanyi I., Lajtha A., Reith M.E. Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatum. Naunyn Schmiedebergs Arch. Pharmacol. 340:1989;626-632.